PCA
ARKG icon

Personal Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Personal Capital Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,691
Closed -$201K – 550
2021
Q3 		$201K Buy
2,691
+32
+1% +$2.69K ﹤0.01% 481
2021
Q2 		$246K Sell
2,659
-5,725
-68% -$487K ﹤0.01% 436
2021
Q1 		$744K Buy
+8,384
New +$832K ﹤0.01% 264

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Personal Capital Advisors's ARKG Position: Q4 2021 in Review

Personal Capital Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 2,691 shares — an estimated $201K sold.

Personal Capital Advisors first reported a position in ARKG in Q1 2021 and held it in 3 quarters. The position peaked at $744K in Q1 2021. 462 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Personal Capital Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • Personal Capital Advisors sold 2,691 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $201K.
  • Personal Capital Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 3 quarters.
  • Personal Capital Advisors's ARK Genomic Revolution ETF position peaked at $744K in Q1 2021.
  • 462 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Personal Capital Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.